AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2016

May 13, 2016

32870_dirs_2016-05-13_f9bb78d2-63f7-4121-ba4d-e169ad9ce91b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-05-11

Reporting Person: SULLIVAN LOUIS W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-11	Common Stock	M	9969	$8.43	Acquired	38469	Direct
2016-05-11	Common Stock	S	9969	$39.25	Disposed	28500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-11	Stock Option	$8.43	M	9969	Disposed	2017-06-13	Common Stock (9969)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan on June 14, 2007.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.66, inclusive.

F3: The option vested in three equal installments in June 2008, 2009 and 2010.